(EurekAlert) Scientists at the University of California, Davis, detected the H1N1 (2009) virus in free-ranging northern elephant seals off the central California coast a year after the human pandemic began, according to a study published today, May 15, in the journal PLOS ONE. It is the first report of that flu strain in any marine mammal.
- May 16, 2013 |
(EurekAlert) Today, the Global Network for Neglected Tropical Diseases (Global Network), a major initiative of the Sabin Vaccine Institute, announced His Excellency, President Alvaro Arzú Irigoyen of Guatemala (1996-2000), His Excellency, President Ricardo Lagos Escobar of Chile (2000-2006) and former Pan American Health Organization (PAHO) Director Dr. Mirta Roses Periago as the organization’s newest Neglected Tropical Disease (NTD) Special Envoys. They will join the efforts of current NTD Special Envoy, His Excellency, President John A. Kufuor of the Republic of Ghana (2001-2009), who was appointed in April 2012. The collaboration was announced at a panel hosted by the Global Network and the Read More »
- May 8, 2013 |
(CSIS) After 25 years of remarkable achievements and sometimes harrowing setbacks, a successful conclusion to global polio eradication could finally be within reach. In late April, the Global Vaccine Summit in Abu Dhabi released the Global Polio Eradication Initiative (GPEI), a promising new six-year strategy to win the polio “endgame.”
- May 2, 2013 |
(MedicalXpress) An international team of bio-researchers has found that a mutant strain of the H5N1 influenza virus (created in a lab) has a 200-fold preference for binding with receptors in human cells, over those found in birds. In describing their research and conclusions in their paper published in the journal Nature, the researchers suggest that the mutant variant is much more like the strains of viruses that caused pandemics in 1918, 1957 and 2009, than it was in its native state.
- April 26, 2013 |
(MedicalNewsToday) IDRI (Infectious Disease Research Institute), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive interim results from a Phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate (“H5N1 vaccine”).
- April 22, 2013 |
Browse by region
Browse By Category
(CSIS) A contradiction sits at the core of U.S. biological threat prevention policy. Despite the U.S. government accepting the scientific and industrial costs of a domestic biosecurity system, it has not committed the diplomatic and financial resources needed to successfully promote the global adoption of similar systems. While the safety and Read More »
- May 8, 2013
(EurekAlert) Today, the Global Network for Neglected Tropical Diseases (Global Network), a major initiative of the Sabin Vaccine Institute, announced His Excellency, President Alvaro Arzú Irigoyen of Guatemala (1996-2000), His Excellency, President Ricardo Lagos Escobar of Chile (2000-2006) and former Pan American Health Organization (PAHO) Director Dr. Mirta Roses Periago as Read More »
- May 8, 2013
(TimesofAssam) The biotechnologically manipulated gene combination, occurring in genetically modified crops owns the potential to overcome several threats of food insecurity, by uprooting the drawbacks of traditional agriculture practices. Economic solutions aside, GM crops with higher yields, better resistance to pests and weeds, shorter maturation periods, tolerance to drastic climatic challenges Read More »
- May 8, 2013
(FoodSafetyNews) Just two months after the White House warned that across-the-board budget cuts, known as the sequester, could have dire consequences for the country, in part because they could weaken food safety protections, it seems food safety has escaped the worst of the impact.
- May 8, 2013
(EurekAlert) Around 150 million people globally are chronically infected with the hepatitis C virus (HCV) – a major cause of liver disease and the fastest growing cause of liver transplantation and liver cancer. 1 New prevention strategies are urgently required as people are continuing to be infected with HCV. Findings, published Read More »
- May 7, 2013